GENB (Generate Biomedicines) Total Operating Expense: $266.96 Mil (TTM As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Total Operating Expense?

Generate Biomedicines GENB +2.18% 6 Total Operating Expense is $266.96 Mil as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Generate Biomedicines's Total Operating Expense for the six months ended in Dec. 2025 was $266.96 Mil. Generate Biomedicines's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $266.96 Mil.

Generate Biomedicines Total Operating Expense Related Terms

Generate Biomedicines Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Total Operating Expense Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Total Operating Expense
217.40 266.96

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Total Operating Expense 217.40 266.96
GENB
6GF Score
Generate Biomedicines Inc GENB
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $266.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $266.96 Mil mean?
Generate Biomedicines (GENB) has a Total Operating Expense of $266.96 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Generate Biomedicines and its competitors.
Is Generate Biomedicines' Total Operating Expense too high?
Generate Biomedicines' current Total Operating Expense is $266.96 Mil. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' Total Operating Expense compare to PVLA and SLBT?
Generate Biomedicines' Total Operating Expense of $266.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Generate Biomedicines and its competitors. Generate Biomedicines's current Total Operating Expense is $266.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current Total Operating Expense of $266.96 Mil. The current Total Operating Expense is $266.96 Mil. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current Total Operating Expense is $266.96 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price